Drugs News and Research

RSS

Researchers seek to identify biomarkers that may predict suicide risk among women

A four-year, $3.1 million grant from the National Institute of Mental Health will help researchers determine how the stabilization of ovarian hormones estradiol and progesterone may help lower symptoms associated with suicidality among females with longstanding thoughts of suicide.

5 Aug 2019

Drugmakers now ‘masters’ at rolling out their own generics to stifle competition

When PDL BioPharma's $40 million blood-pressure medicine faced the threat of a generic rival this year, the company pulled out a little-known strategy that critics say helps keep drugs expensive and competition weak.

5 Aug 2019

FDA announces new policy framework for development of regenerative medicine products

Today the U.S. Food and Drug Administration announced a comprehensive policy framework for the development and oversight of regenerative medicine products, including novel cellular therapies.

5 Aug 2019

Whole body vibration adjusts the microbiome and immune cells to deter inflammation in diabetes

In the face of diabetes, a common condition in which glucose and levels of destructive inflammation soar, whole body vibration appears to improve how well our body uses glucose as an energy source and adjust our microbiome and immune cells to deter inflammation, investigators report.

5 Aug 2019

Study could open a new era in transplantation medicine

For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.

5 Aug 2019

New tool makes it easier to study how influenza viruses cause disease

Studying how influenza viruses cause disease just got a little easier, thanks to a new tool developed at South Dakota State University.

3 Aug 2019

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery.

3 Aug 2019

Scientists use AI to recognize patterns in breast cancer

Scientists have used artificial intelligence to recognize patterns in breast cancer - and uncovered five new types of the disease each matched to different personalized treatments.

2 Aug 2019

New model predicts cognitive decline of patients at risk for Alzheimer’s disease

A new model developed at MIT can help predict if patients at risk for Alzheimer's disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future.

2 Aug 2019

If you smoke pot, your anesthesiologist needs to know

When Colorado legalized marijuana, it became a pioneer in creating new policies to deal with the drug.

2 Aug 2019

Blood test may accurately identify people with early Alzheimer's brain changes

Up to two decades before people develop the characteristic memory loss and confusion of Alzheimer's disease, damaging clumps of protein start to build up in their brains.

2 Aug 2019

Discovery of distinct lung cancer pathways could help future patients

Known for its poor prognosis, lung adenocarcinoma is the most common type of lung cancer, responsible for about 4 of 10 diagnoses, according to the National Cancer Institute.

2 Aug 2019

Infusion treatments for low iron can deplete patients’ wallets

Shannon Wood Rothenberg walked into her annual physical feeling fine. But more than a year later, she's still paying the price.

2 Aug 2019

Rare immune cells may serve as 'periscopes' to monitor the body's immune status, study finds

A rare, short-lived population of immune cells in the bloodstream may serve as 'periscopes' to monitor immune status via lymph nodes deep inside the body, according to researchers in the Perelman School of Medicine at the University of Pennsylvania.

2 Aug 2019

Company expands development plans for drugs which slow progression to dialysis

Kibow Biotech announces that the focus on supporting and maintaining healthy kidney function with probiotics/prebiotics to potentially delay the progression to dialysis is based on its enteric toxin reduction platform technology termed "Enteric Dialysis®"

From Kibow Biotech Inc. 2 Aug 2019

Drugs News and Research

Researchers seek to identify biomarkers that may predict suicide risk among women

Drugmakers now ‘masters’ at rolling out their own generics to stifle competition

FDA announces new policy framework for development of regenerative medicine products

Whole body vibration adjusts the microbiome and immune cells to deter inflammation in diabetes

Study could open a new era in transplantation medicine

New tool makes it easier to study how influenza viruses cause disease

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

Scientists use AI to recognize patterns in breast cancer

New model predicts cognitive decline of patients at risk for Alzheimer’s disease

If you smoke pot, your anesthesiologist needs to know

Blood test may accurately identify people with early Alzheimer's brain changes

Discovery of distinct lung cancer pathways could help future patients

Infusion treatments for low iron can deplete patients’ wallets

Rare immune cells may serve as 'periscopes' to monitor the body's immune status, study finds

Company expands development plans for drugs which slow progression to dialysis

Alzheimers may be linked to genes that code formation of contacts between neurons

New drug combination successfully reduces levels of bovine leukemia virus

Researchers reveal undiscovered hot spots on surface of bacteria's critical enzyme

California bill would fight deals that delay generic drugs

New antibiotics on the horizon as scientists discover a weakness in the cell wall of pathogenic bacteria

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News